ハイドロキノン外用剤による色素沈着症の治療:—後天的炎症後色素沈着について—
スポンサーリンク
概要
- 論文の詳細を見る
Hydroquinone is known to a superexcellent melanoanalysis agent both in vivo and in vitro. Hydroquinone formulated in ointment is found to be austere, and side effects of ointment used for depigmentation are greatly censured because of stability. In the study, a new hydroquinone ointment was developed by formulating L-ascorbic acid (0.3%) as a reducing agent and hydrocortisone acetate (1%) as an anti-inflammatory agent which was seen proven to be safe for repeated applications without any side effects. This ointment has been proven to be stable for a fairly long time and effective therapy to pigmentation as post-inflammation.
- 日本皮膚科学会西部支部の論文
日本皮膚科学会西部支部 | 論文
- 症例 Toxic Epidermal Necrolysis(TEN)型皮疹を呈したDrug-Induced Hypersensitivity Syndrome(DIHS)の1例
- Hydrocortisone17-Butyrate外用剤(Locoid)の使用経験--とくに弗素化ステロイド長期外用例について
- 多彩な皮膚病変を呈した慢性GVHDの1例
- Lupus Erythematosus Profundus に伴って筋の線維化を認めた1例
- 尿素外用剤塗布後の快適性に関する調査